Dementia With Lewy Bodies (DLB)
3 competing products in clinical development for Dementia With Lewy Bodies (DLB).
Pipeline by Phase
Phase 22
Phase 31
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Donepezil 5 mg + Donepezil 10 mg + Donepezil matched placebo | Eisai | Phase 3 | Completed | 40 |
| 3 mg Donepezil hydrochloride + 5 mg Donepezil hydrochloride + 10 mg Donepezil hydrochloride + Placebo | Eisai | Phase 2 | Completed | 35 |
| E2020 | Eisai | Phase 2 | Completed | 35 |